Drugs / RSV-F Particle Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01290419 | Dec 2010 → Dec 2011 | respiratory syncytial virus infectious disease | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSV-F Particle Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01290419 ↗ |
| Modality | Vaccine | “a recombinant respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine” PMID 23153449 ↗ Nov 2012 |
| Route | Intramuscular | “were administered intramuscularly on day 0 and 30” PMID 23153449 ↗ Nov 2012 |